Article
PRAME Gene Copy Number Variation Is Related to Its Expression in Multiple Myeloma
27 Sept 2017
Abstract excerpt
Multiple myeloma (MM) patients commonly present abnormal expression of cancer-testis antigens, which may serve as immunotherapeutic targets and prognostic factors. We previously reported that preferentially expressed antigen of melanoma (PRAME) overexpression in bone marrow mononuclear cells is related to progression in MM patients treated with non-bortezomib-containing regimens. The mechanism underlying...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
